Back
Speaker illustration

Doctor Jonas Goldin Diness

Acesion Pharma, Copenhagen (Denmark)

Member of:

European Society of Cardiology

Presentations

The SK channel inhibitor AP30663, converts vernakalant-resistant persistent AF and prevents its reinduction in pigs

Event: ESC Congress 2019

Topic: Antiarrhythmic Pharmacotherapy

Session: Preclinical pharmacotherapy

Access
Like
Thumbnail

Novel negative, allosteric modulator inhibits small conductance Ca2+-activated K+-channels and selectively prolongs atrial refractoriness in conscious pigs

Event: ESC Congress 2017

Topic: Atrial fibrillation (AF)

Session: Atrial fibrillation mechanisms

Access
Like
Thumbnail

Inhibition of small conductance Ca2+-activated K+-Channels converts and prevents reinduction of atrial fibrillation in pigs where vernakalant fails

Event: ESC Congress 2016

Topic: Atrial fibrillation (AF)

Session: Mechanism of arrhythmia in atrial fibrillation . New data on remodelling biomarkers and anti-arrhythmic drugs

Access
Like
Thumbnail

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources